National Network Genomic Medicine Lung Cancer, Germany
Recruiting · NCT05934032 · Observational (researchers observe without assigning treatment) · Lead sponsor: Prof. Dr. Juergen Wolf
View the official record on ClinicalTrials.gov →Interventions studied
observational, non-interventional
What this trial is about
Registry of the national Network Genomic Medicine Lung Cancer (nNGM), linking data on molecular diagnostics, clinical characteristics, treatment patterns and outcomes of subjects with non-small cell lung cancer (NSCLC) from 23 specialized cancer centres and more than 400 general hospitals and oncological practices in Germany
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Age ≥ 18 years
- Histologically confirmed, locally advanced or metastatic NSCLC (Union for International Cancer Control \[UICC\] stage IIIb/IV; non-resectable NSCLC)
- From 07/2023: histologically confirmed NSCLC stage Ib, II, III (UICC)
Exclusion criteria
- Missing written informed consent
Where it is running
1 location listed.
- University Hospital Cologne - Cologne, Germany